← Back to patent-cliff list
Proline-rich peptide hydrogel (Complutense University Of Madrid)
Tier C — Watch / tradeProline-rich peptide hydrogel (Complutense University Of Madrid)
Complutense University Of Madrid
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Updating
Indications (approved)：牙周疾病
Regional status
US
-
EU
Phase II
2026-04-27
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Proline-rich peptide hydrogel (Complutense University Of Madrid)?
Approved indications include: 牙周疾病.
When does the Proline-rich peptide hydrogel (Complutense University Of Madrid) patent expire?
No public expiry year is available for Proline-rich peptide hydrogel (Complutense University Of Madrid) yet; this page updates once verified.
How do I get a quote for Proline-rich peptide hydrogel (Complutense University Of Madrid) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29